Adeno-associated virus production of soluble tumor necrosis factor receptor neutralizes tumor necrosis factor α and reduces arthritis

Human Gene Therapy

Volumn 11, Issue 17, 2000, Pages 2431-2442

  Zhang, H G ^a   Xie, J ^a   Yang, P ^a   Wang, Y ^a   Xu, L ^a   Liu, D ^a   Hsu, H C ^a   Zhou, T ^a   Edwards III, C K ^b   Mountz, J D ^a,c  

^a MEB 625   (United States)

^b AMGEN INC   (United States)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; VIRUS VECTOR; COLLAGENASE; LEUKOCYTE ANTIGEN; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CELL HYPERPLASIA; CONTROLLED STUDY; FEMALE; GENE THERAPY; GENETIC TRANSDUCTION; MOUSE; NONHUMAN; SYNOVIOCYTE; TRANSGENIC MOUSE; VIRUS NEUTRALIZATION; VIRUS PARTICLE; ANIMAL; CELL CULTURE; DRUG EFFECT; FIBROBLAST; GENETICS; HUMAN; L CELL; METABOLISM; METHODOLOGY; MUSCLE; PATHOLOGY; RHEUMATOID ARTHRITIS; SYNOVITIS; TOXICITY TESTING; VIROLOGY;

ANIMALS; ANTIGENS, CD; ARTHRITIS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; COLLAGENASES; DEPENDOVIRUS; FEMALE; FIBROBLASTS; GENE THERAPY; HUMANS; L CELLS (CELL LINE); MICE; MICE, TRANSGENIC; MUSCLES; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECOMBINANT PROTEINS; SYNOVITIS; TOXICITY TESTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034693936     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303400750038525     Document Type: Article

References (33)

1. A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling
2. Inhibition of the production and effects of interleukin-1 tumor and necrosis factor alpha in rheumatoid arthritis
3. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin
4. Effects of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) alone and in combination with methotrexate in adjuvant arthritic rats
5. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases
6. DBA/ mice expressing the human TNF-alpha transgene develop a severe, erosive arthritis: Characterization of the cytokine cascade and cellular composition
7. Persistence in muscle of an adenoviral vector that lacks all viral genes
8. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity
9. PEGylated recombinant human soluble tumor necrosis factor receptor type I (r-Hu-sTNF-RI): Novel high affinity TNF receptor designed for chronic inflammatory diseases
10. Gene therapy and RA. Getting genes into human synovium
11. Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram-negative sepsis
12. Role of cytokines in rheumatoid arthritis
13. Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group
14. Recombinant adeno-associated virus for muscle directed gene therapy
15. Hightiter adeno-associated viral vectors from a rep/cap cell line and hybrid shuttle virus
16. Direct adenovirus-mediated gene transfer of interleukin and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects
17. Transgenic mice expressing human tumour necrosis factor: A predictive genetic model of arthritis
18. Viral IL-10 and soluble TNF receptor act synergistically to inhibit collagen-induced arthritis following adenovirus-mediated gene transfer
19. Suppression of collagen-induced arthritis through adenovirus-mediated transfer of a modified tumor necrosis factor alpha receptor gene
20. In vivo blockade of tumor necrosis factor-alpha in patients with rheumatoid arthritis: Long term effects after repeated infusion of chimeric monoclonal antibody cA2
21. PhaseI/II study to evaluate the safety, immunogenicity, pharmacokinetics and potential efficacy of IV rHuTNF binding protein pegylated dimer (TNFbp) in patient with active RA
22. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein
23. A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal
24. Recombinant human parvovirus B19 vectors: Erythroid cell-specific delivery and expression of transduced genes
25. Viral vectors for gene therapy
26. Helper-free stocks of recombinant adeno-associated viruses normal integration does not require viral gene expression
27. Reduction of arthritis and pneumonitis in motheaten mice by soluble tumor necrosis factor receptor
28. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate
29. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses
30. Characterization of a SV-40 transformed rheumatoid synovial fibroblast cell line which retains genotypic expression patterns: A model for evaluation of anti-arthritis agents in vitro
31. Inhibition of tumor necrosis factor alpha decreases inflammation and prolongs adenovirus gene expression in lung and liver
32. Gene therapy that inhibits nuclear translocation of nuclear factor kappa B results in tumor necrosis factor alpha-induced apoptosis of human synovial fibroblasts